Screening Breast Cancer: the Mammography War

被引:0
作者
Srinivasan A. [1 ]
Parris T. [2 ]
机构
[1] Department of Diagnostic Radiology, Division of Diagnostic Imaging, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, 77030-4009, TX
[2] The Breast Care Center of Temecula Valley, 25455 Medical Center Drive, Murrieta, 92562, CA
关键词
Breast cancer mortality; Breast cancer screening; Breast cancer screening guidelines; Screening mammogram;
D O I
10.1007/s12609-016-0222-7
中图分类号
学科分类号
摘要
There is an established consensus in the breast health community that mammography is the mainstay imaging examination for screening breast cancer. However, there are varied national recommendations among stakeholders and major institutions in the topic of breast cancer screening. Lack of consensus in screening criteria includes risk stratification, age to initiate screening, and the interval of screening. The differences in practice guidelines are mainly due to variation in design and interpretation of screening trials over the past decades. As debates for and against the use of screening mammography continue to escalate, both providers and patients are often confused and wrongly perceive the recommendations as directives. The purpose of this article is to review the current guidelines, analyze the reason for the controversies in screening mammography, and shine light on the upcoming trends of future screening guidelines. © 2016, Springer Science+Business Media New York.
引用
收藏
页码:206 / 212
页数:6
相关论文
共 28 条
[1]  
(2016)
[2]  
Nelson H.D., Et al., Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis, Ann Intern Med, 156, 9, pp. 635-648, (2012)
[3]  
The benefits and harms of breast cancer screening: an independent review, Lancet, 380, 9855, pp. 1778-1786, (2012)
[4]  
Nelson H.D., Et al., Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. preventive services task force recommendation, Ann Intern Med, 164, 4, pp. 244-255, (2016)
[5]  
Block L.D., Et al., Mammography use among women ages 40–49 after the 2009 U.S. Preventive Services Task Force recommendation, J Gen Intern Med, 28, 11, pp. 1447-1453, (2013)
[6]  
Pace L.E., Keating N.L., A systematic assessment of benefits and risks to guide breast cancer screening decisions, JAMA, 311, 13, pp. 1327-1335, (2014)
[7]  
Bleyer A., Baines C., Miller A.B., Impact of screening mammography on breast cancer mortality, Int J Cancer, 138, 8, pp. 2003-2012, (2016)
[8]  
Tabar L., Et al., Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades, Radiology, 260, 3, pp. 658-663, (2011)
[9]  
Bjurstam N.G., Bjorneld L.M., Duffy S.W., Updated results of the Gothenburg Trial of Mammographic Screening, Cancer, 122, 12, pp. 1832-1835, (2016)
[10]  
Moss S.M., Et al., Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years’ follow-up: a randomised controlled trial, Lancet Oncol, 16, 9, pp. 1123-1132, (2015)